Security Name | Ticker | % of Net Assets |
---|---|---|
ABBVIE INC | ABBV | 7.29% |
AMGEN INC. | AMGN | 4.86% |
VERTEX PHARMACEUTICALS | VRTX | 4.60% |
GILEAD SCIENCES, INC. | GILD | 4.50% |
REGENERON PHARMACEUTICALS | REGN | 3.44% |
CORTEVA INC | CTVA | 3.21% |
ALNYLAM PHARMACEUTICALS | ALNY | 2.80% |
BEIGENE LTD ADR | BGNE | 2.29% |
NATERA INC | NTRA | 2.27% |
ASTRAZENECA PLC ADR | AZN | 2.21% |
ROYALTY PHARMA PLC- CL A | RPRX | 1.94% |
BIOGEN IDEC, INC. | BIIB | 1.87% |
UNITED THERAPEUTICS CORP | UTHR | 1.77% |
INSMED INC | INSM | 1.68% |
ILLUMINA INC | ILMN | 1.60% |
EXELIXIS, INC. | EXEL | 1.57% |
BIOMARIN PHARMACEUTICAL | BMRN | 1.56% |
NEUROCRINE BIOSCIENCES IN | NBIX | 1.54% |
ARGENX SE - ADR | ARGX | 1.47% |
EXACT SCIENCES | EXAS | 1.46% |
VIATRIS INC | VTRS | 1.45% |
INCYTE CORP | INCY | 1.39% |
GUARDANT HEALTH INC | GH | 1.34% |
MODERNA INC | MRNA | 1.32% |
HALOZYME THERAPEUTICS INC | HALO | 1.30% |
REVOLUTION MEDICINES INC | RVMD | 1.30% |
BIONTECH SE-ADR | BNTX | 1.29% |
TG THERAPEUTICS | TGTX | 1.27% |
ADMA BIOLOGICS INC | ADMA | 1.26% |
BRIDGEBIO PHARMA INC | BBIO | 1.24% |
LEGEND BIOTECH CORP-ADR | LEGN | 1.15% |
JAZZ PHARMACEUTICALS PLC | JAZZ | 1.14% |
BLUEPRINT MEDICI | BPMC | 1.13% |
ROIVANT SCIENCES LTD | ROIV | 1.10% |
ALKERMES PLC | ALKS | 1.08% |
MEDPACE HOLDINGS | MEDP | 1.03% |
CYTOKINETICS INC | CYTK | 1.03% |
CRISPR THERAPEUTICS AG | CRSP | 1.02% |
IONIS PHARMACEUTICALS, IN | IONS | 0.98% |
AXSOME THERAPEUT | AXSM | 0.91% |
SAREPTA THERAPEU | SRPT | 0.90% |
AVIDITY BIOSCIENCES INC | RNA | 0.88% |
ULTRAGENYX PHARM | RARE | 0.86% |
SPRINGWORKS THERAPEUTICS | SWTX | 0.85% |
SUMMIT THERAPEUTICS INC | SMMT | 0.84% |
PTC THERAPEUTICS | PTCT | 0.82% |
CRINETICS PHARMACEUTICALS | CRNX | 0.81% |
VIKING THERAPEUTICS INC | VKTX | 0.80% |
VERACYTE INC | VCYT | 0.76% |
DENALI THERAPEUT | DNLI | 0.72% |
PROTAGONIST THER | PTGX | 0.72% |
ASCENDIS PHA-ADR | ASND | 0.70% |
RECURSION PHARMACEUTICALS | RXRX | 0.70% |
ARCELLX INC | ACLX | 0.70% |
VAXCYTE INC | PCVX | 0.69% |
TWIST BIOSCIENCE CORP | TWST | 0.69% |
AMICUS THERAPEUTICS INC | FOLD | 0.67% |
NUVALENT INC-A | NUVL | 0.63% |
IDEAYA BIOSCIENCES INC | IDYA | 0.63% |
MADRIGAL PHARMAC | MDGL | 0.60% |
BEAM THERAPEUTICS INC | BEAM | 0.60% |
ACADIA PHARMACEUTICALS IN | ACAD | 0.60% |
ARROWHEAD PHARMACEUTICALS | ARWR | 0.60% |
APELLIS PHARMACE | APLS | 0.58% |
AGIOS PHARMACEUT | AGIO | 0.57% |
CELLDEX THERAPEUTICS INC | CLDX | 0.54% |
DYNAVAX TECHNOLOGY | DVAX | 0.52% |
KRYSTAL BIOTECH INC | KRYS | 0.51% |
DYNE THERAPEUTICS INC | DYN | 0.50% |
IOVANCE BIOTHERAPEUTICS | IOVA | 0.50% |
IMMUNOVANT INC | IMVT | 0.44% |
NOVAVAX INC | NVAX | 0.43% |
INTELLIA THERAPE | NTLA | 0.41% |
GERON CORP | GERN | 0.26% |
Other (Cash, derivatives and other liabilities) | 0.31% | |
Total: |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, GS GAMMA Advisors, LLC, and Guggenheim Private Investments, LLC.
© 2025 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.